Overview
- 39 inspections across 38 sites are on record.
- 221 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-01-16.
At a glance
Inspections
39
Sites
38
Observations
221
Career since
Mar 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 16 Jan 2026 | Human Drugs | On file |
| Universal Farma SL | 4 Feb 2025 | Human Drugs | |
| Takeda Austria GmbH | 12 Nov 2024 | Human Drugs | On file |
| Sharp Sterile Manufacturing, LLC | 21 Oct 2024 | Human Drugs | On file |
| Cilag AG | 23 Sep 2024 | Human Drugs | On file |
Sites inspected
Regeneron Pharmaceuticals, Inc.East Greenbush, United States1 insp.
Universal Farma SLAzuqueca De Henares, Spain1 insp.
Takeda Austria GmbHLinz, Austria1 insp.
Sharp Sterile Manufacturing, LLCLee, United States1 insp.
Cilag AGSchaffhausen, Switzerland1 insp.
Co-investigators
Investigators who share inspections with this person.
Katherine E Jacobitz3 shared
Hamet M Toure2 shared
Khalid M Khan2 shared
Adam R Cooke2 shared
Walden H Lee2 shared
William J Leonard2 shared
Jose E Melendez2 shared
Uttaniti Limchumroon2 shared
Terrance L Thomas2 shared
Arie Menachem2 shared
Full investigator report
Get the verbatim findings behind Cassandra L Abellard's 221 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site